Policy Brief 46, March 2018
Outcomes of the 142nd session of the WHO Executive Board
The 142nd session of the WHO Executive Board discussed several critical public health issues including a recommendation to the WHA to approve the General Program of Work (GPW), the adoption of important decisions relating to access to medicines and research and development and a draft resolution on the preparation of the UN High Level Meeting on Tuberculosis.
Download the policy brief below:
This article was tagged: Access to Medicines, Antimicrobial Resistance (AMR), Health, Innovation, Intellectual Property, Public Health, Research and Development (R&D), WHO, WHO Executive Board (EB), World Health Assembly (WHA), World Health Organization (WHO)